PODD logo

Insulet Corporation (PODD)

$249.38

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PODD

Market cap

$17.54B

EPS

3.48

P/E ratio

70.3

Price to sales

6.75

Dividend yield

--

Beta

1.411132

Price on PODD

Previous close

$241.89

Today's open

$245.85

Day's range

$243.67 - $250.41

52 week range

$230.05 - $354.88

Profile about PODD

CEO

Ashley McEvoy

Employees

3900

Headquarters

Acton, MA

Exchange

Nasdaq Global Select

Shares outstanding

70346898

Issue type

Common Stock

PODD industries and sectors

Healthcare

Medical Equipment & Supplies

News on PODD

Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations

Insulet Q4 Earnings Review: Strong Performance Meets Sky-High Expectations

news source

Seeking Alpha • Feb 19, 2026

news preview

PODD Stock Up on Q4 Earnings & Revenue Beat, Margins Rise

Insulet jumps after Q4 EPS and revenue beat, margin expansion and record Omnipod growth power a strong 2025 finish and upbeat 2026 outlook.

news source

Zacks Investment Research • Feb 19, 2026

news preview

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Insulet reported better-than-expected fourth-quarter results on Wednesday, on the back of strong demand for its tubeless insulin pumps that eliminate the need for daily injections.

news source

Reuters • Feb 18, 2026

news preview

Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript

Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript

news source

Seeking Alpha • Feb 18, 2026

news preview

Insulet Reports Fourth Quarter and Full Year 2025 Results

ACTON, Mass.--(BUSINESS WIRE)--Insulet Reports Fourth Quarter and Full Year 2025 Results.

news source

Business Wire • Feb 18, 2026

news preview

Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars

Insulet Corporation  (NASDAQ: PODD) stock is trading higher on Wednesday after the company reported better-than-expected fourth-quarter earnings and 2026 guidance.

news source

Benzinga • Feb 18, 2026

news preview

Insulet (PODD) Tops Q4 Earnings and Revenue Estimates

Insulet (PODD) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.15 per share a year ago.

news source

Zacks Investment Research • Feb 18, 2026

news preview

Insulet (PODD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Insulet (PODD) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Feb 18, 2026

news preview

Exploring Analyst Estimates for Insulet (PODD) Q4 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Insulet (PODD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

news source

Zacks Investment Research • Feb 12, 2026

news preview

Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth

Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Feb 11, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Insulet Corporation

Open an M1 investment account to buy and sell Insulet Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PODD on M1